Abstract

<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:HyphenationZone>21</w:HyphenationZone> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> </w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" LatentStyleCount="156"> </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object> <style>
 st1\:*{behavior:url(#ieooui) }
 </style> <![endif]--><!--[if gte mso 10]> <style>
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Tabela normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-parent:"";
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
 mso-para-margin:0cm;
 mso-para-margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:"Times New Roman";
 mso-ansi-language:#0400;
 mso-fareast-language:#0400;
 mso-bidi-language:#0400;}
 </style> <![endif]--> <p class="MsoNormal" style="margin: 0cm 22.7pt 0.0001pt; text-align: justify;"><strong><span style="font-size: 8pt; color: black;">Introdução: </span></strong><span style="font-size: 8pt;">Dentre os biomateriais para regeneração óssea, os de origem xenogênica têm se mostrado como alternativa ao autoenxerto devido às suas propriedades biológicas e físico-químicas, além de sua grande disponibilidade e de minimizar a morbidade ao indivíduo. Vários trabalhos consideram o BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;">®</span><span style="font-size: 8pt;">, uma hidroxiapatita bovina, como padrão ouro entre os biomateriais de substituição óssea, independentemente do tamanho de suas partículas, apesar de esse fator ser considerado importante nas reações tissulares envolvidas na neoformação óssea. <strong>Objetivo: </strong>Avaliar histologicamente o comportamento biológico de uma Hidroxiapatita Bovina, na forma de grânulos, entre 0,4 a 0,6 mm, implantados em defeitos ósseos críticos em calvária de rato. <strong>Metodologia: </strong>Foram utilizados 20 ratos distribuídos em 2 grupos experimentais:<span> </span>Grupo GC (controle com coágulo) e Grupo GBS (implantados com hidroxiapatita bovina) nos quais foi efetuado um defeito crítico de 8,5 mm de diâmetro na calvária. A eutanásia foi realizada em dois pontos biológicos, aos 15 e 45 dias pós-operatórios e os<span> </span>espécimes<span> </span>foram processados para inclusão em parafina. Os cortes histológicos foram corados pela técnica de hematoxilina e eosina (HE), e<span> </span>picrossírius-vermelho (PIFG), e foram analisados histologicamente em microscópio de luz comum. <strong>Resultados: </strong>No grupo controle, observou-se, neoformação óssea reacional restrita às bordas e presença de tecido fibroso na área do defeito. No grupo implantado com BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;">®</span><span style="font-size: 8pt;">, observou-se mínima reação inflamatória, abundante angiogênese e alguma osteogênese, além das bordas, ao longo do defeito, especialmente em continuidade à dura-máter. <strong>Conclusão:</strong> Concluiu-se que o BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;">®</span><span style="font-size: 8pt;"><span> </span>foi biocompatível e promoveu osteogênese por osteocondução, mantendo-se parcialmente integrado ao osso neoformado.</span></p> <p class="MsoNormal" style="margin: 0cm 22.7pt 0.0001pt;"><span style="font-size: 8pt; color: black;" lang="EN-US"> </span></p> <p class="MsoNormal" style="margin: 0cm 22.7pt 0.0001pt; text-align: justify;"><strong><span style="font-size: 8pt; color: black;" lang="EN-US">Abstract</span></strong></p> <p class="MsoNormal" style="margin: 0cm 22.7pt 0.0001pt; text-align: justify;"><strong><span style="font-size: 8pt; color: black;" lang="EN-US">Introduction</span></strong><span style="font-size: 8pt;" lang="EN-US">: Among the biomaterials for bone regeneration materials of xenogeneic origin have shown up as an alternative to autografts. This is, in addition to its wide availability, and its ability to minimize the morbidity of the individual, due to its biological and physical-chemical properties. Several papers consider BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;" lang="EN-US">®</span><span style="font-size: 8pt;" lang="EN-US">, a bovine hydroxyapatite, as the gold standard among biomaterials for bone replacement. The size of its particles is irrelevant to this statement, although it is considered an important factor in tissue reactions during bone formation. <strong>Objective</strong>: The objective was to evaluate histologically the biological behavior of BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;" lang="EN-US">® </span><span style="font-size: 8pt;" lang="EN-US">in the form of granules (0.4 mm to 0.6 mm) implanted in critical bone defects in rat calvaria. <strong>Materials and Methods:</strong> 20 rats were divided into two experimental groups: GC (control, no implantation, defect filled with clot) and GBS (implantation with BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;" lang="EN-US">®</span><span style="font-size: 8pt;" lang="EN-US">). A critical defect of 8.5 mm was introduced into the calvaria of the rats. Euthanasia was performed at the biological time points of 15 and 45 days post operatively. In order to finalize the processing, the specimens i.e. the histological sections were either stained with hematoxylin and eosin (<span style="color: #1a1a1a;">H&E stain)</span><span style="color: black;">, or picrosirius-red (PIFG). The analyses were made by common light microscopy. </span><strong>Results</strong>: In the GC-group reactive new bone formation, restricted to the edges of the defect, and the presence of fibrous tissue throughout the majority of the defect area, were observed. In the GBS-group minimal inflammatory response, abundant angiogenesis, and osteogenesis were detected beyond the edges of the defect, especially in proximity to the <em>dura mater</em>. <strong>Conclusion: </strong>In conclusion, BioOss</span><span style="font-size: 4.5pt; position: relative; top: -2.5pt;" lang="EN-US">®</span><span style="font-size: 8pt;" lang="EN-US"><span> </span>can be considered biocompatible. It promotes osteogenesis, by osteoconduction, and is partly integrated in newly formed bone.</span></p>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.